EOF
Click for more information
0.00% 2.9¢ ecofibre limited

Recce Pharmaceuticals (ASX:RCE) gains ethics approval to start burns study

  1. TheMarketOnline
    7,803 Posts.
    lightbulb Created with Sketch. 1149
    clock Created with Sketch.
    16/10/20
    12:50
    Post #: 48147944
    Recce Pharmaceuticals (RCE) has been granted ethics approval to start a phase one/two study on patients with infected burn wounds sponsored by WA’s South Metropolitan Health Service with Fiona Stanley Hospital as the study site.

    Read the full article on The Market Herald.
    EOF Price at posting: $2.50 Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS First paediatric clinical site activated – major recruitment milestone and key appointment announced
right-arrow Created with Sketch.
NEWS A$17 Million Cash Sale of Citadel Joint Venture Interest
right-arrow Created with Sketch.
NEWS $2.2M Placement to Expand Resources and Continue Exploration
right-arrow Created with Sketch.
LU7 Discover the world of North American lithium chemicals with the "Dream Team"
right-arrow Created with Sketch.
NEWS PLS: HotCopper's Most Discussed Stock of The Week!
right-arrow Created with Sketch.
NEWS Rock Chip results up to 170g/t Au on Komboro at Napie
right-arrow Created with Sketch.
watchlist Created with Sketch. Add EOF (ASX) to my watchlist
(20min delay)
Last
2.9¢ 		Change
0.000(0.00%) 		Mkt cap ! $10.98M
Open High Low Value Volume
2.6¢ 2.9¢ 2.6¢ $596 20.75K

Buyers (Bids)

No. Vol. Price($)
1 28000 2.6¢
 

Sellers (Offers)

Price($) Vol. No.
3.3¢ 30272 1
View Market Depth
Last trade - 12.48pm 13/09/2024 (20 minute delay) ?
EOF (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.